Development of Clinical and Biological Database
Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Feb 27, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a valuable database for different types of cancer, including digestive, gynecologic, breast cancer, and sarcoma. The goal is to help researchers better understand cancer by collecting important clinical and biological information. This information can lead to new ways to prevent, diagnose, and treat various cancer types, ultimately improving patient care.
To participate, individuals must be at least 18 years old and have a confirmed or suspected invasive tumor related to the cancers being studied. They should not have started any treatment for their cancer yet and must be willing to provide extra blood samples for research. If you or someone you know meets these criteria, participating in this trial can contribute to important cancer research that may benefit many patients in the future. It's important to note that pregnant or nursing women and those in emergency situations cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\> at 18 years old,
- • Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,
- • Patient in ICM at diagnosis
- • a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or
- • gynecological cancer (ovary, endometrium, cervix) or
- • breast cancer or
- • sarcoma.
- • Naïve patient of any treatment for the present cancer,
- • Patient requiring treatment involving at least one (or more) tumor surgery (s)
- • Patient who has accepted supplementary blood samples,
- • Patient having given his informed, written and express consent.
- Exclusion Criteria:
- • Patient not affiliated to a social protection scheme,
- • Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons,
- • Pregnant and / or nursing women,
- • Subject under tutelage, curatorship or safeguard of justice,
- • Patient in an emergency situation.
About Institut Du Cancer De Montpellier Val D'aurelle
The Institut du Cancer de Montpellier - Val d'Aurelle is a leading cancer research and treatment center located in Montpellier, France. Committed to advancing oncology through innovative clinical trials and research initiatives, the institute integrates cutting-edge scientific discovery with patient-centered care. With a multidisciplinary team of experts, it focuses on developing new therapeutic strategies and improving outcomes for cancer patients. The institute fosters collaboration with academic institutions and industry partners, aiming to translate research findings into effective clinical applications for a diverse range of cancers.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Trial Officials
jean pierre Bleuse
Study Chair
Institut régional du Cancer de Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials